yes i take peptides · shopping companion

PT-141

Bremelanotide / Vyleesi

Category · For WetStatus · FDACitations · 60

The verdict

Yes for documented HSDD via the FDA-approved pathway — depends for off-label "date-night" use.

By source — cost, legality, risk

Brand — Vyleesi (bremelanotide)
$900–$1,000 per 4-pack cash (~$290/dose)
FDA-approved Rx · HSDD in premenopausal women, auto-injector
Lowest. The trial drug; on-label is for women only.
Compounded 503A pharmacy
$80–$300/mo (nasal spray or injectable)
Rx · widely off-label via telehealth and sex-medicine clinics
Lowest of the off-label lanes. Pharmacy-grade; the dominant off-label channel.
RUO research peptide
$30–$70/mo
Sold 'for research only'
Highest. Sometimes substituted with MT-II (stronger pigmentation and nausea — neither is what the buyer paid for).
Gray-market raw
$5–$10/mo
Unregulated overseas import
Same upstream molecule as RUO. Crypto/Wise pay; per-mg cost is roughly 1/7 of RUO retail.

Stop signals · abort if

chest pain, sustained hypertension, severe persistent headache, new mole or changing mole, severe nausea that doesn't resolve, fainting

Sources · top 5 of 60

01Hedlund P. PT-141 Palatin. Current opinion in investigational drugs (London, England : 2000). 2004;5(4):456-62. PMID: 15134289.
02Nappi RE, et al. Medical Treatment of Female Sexual Dysfunction. The Urologic clinics of North America. 2022;49(2):299-307. PMID: 35428435.
03— Bremelanotide. 2021. PMID: 34436837.
04— Bremelanotide. 2025. PMID: 31369224.
05Dhillon S, et al. Bremelanotide: First Approval. Drugs. 2019;79(14):1599-1606. PMID: 31429064.